|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Roger L. LundbladPublisher: Taylor & Francis Ltd Imprint: CRC Press Weight: 0.453kg ISBN: 9781138114944ISBN 10: 1138114944 Pages: 368 Publication Date: 31 May 2017 Audience: College/higher education , General/trade , Tertiary & Higher Education , General Format: Paperback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsLundblad (pathology, U. of North Carolina at Chapel Hill) provides coverage of the range of technology used for the conformational analysis of biopharmaceutical polymers, intending to provide sufficient information and extensive references to establish the basis for the selection of a specific experimental approach that would be most cost-effective in the study of biopolymer conformation. Technologies addressed include native electrophoresis, affinity chromatography, size-exclusion chromatography, analytical ultracentrifugation, differential scanning calorimetry, light scattering, luminescence, near-infrared spectroscopy, mid-infrared and Fourier transform infrared spectroscopy, Raman spectroscopy, UV-VIS spectroscopy, optical rotatory dispersion and circular dichroism, nuclear magnetic resonance, chemical probes, hydrogen exchange, chemical modification,. immunology, and limited proteolysis -2010 Book News Inc., Portland, Oregon Without any hesitation, I recommend this book to any researcher involved in the analysis of conformation and stability of biotechnology products (not necessarily limited to biopharmaceuticals). -Igor A Kaltashov. Future Science """Lundblad (pathology, U. of North Carolina at Chapel Hill) provides coverage of the range of technology used for the conformational analysis of biopharmaceutical polymers, intending to provide sufficient information and extensive references to establish the basis for the selection of a specific experimental approach that would be most cost-effective in the study of biopolymer conformation. Technologies addressed include native electrophoresis, affinity chromatography, size-exclusion chromatography, analytical ultracentrifugation, differential scanning calorimetry, light scattering, luminescence, near-infrared spectroscopy, mid-infrared and Fourier transform infrared spectroscopy, Raman spectroscopy, UV-VIS spectroscopy, optical rotatory dispersion and circular dichroism, nuclear magnetic resonance, chemical probes, hydrogen exchange, chemical modification,. immunology, and limited proteolysis"" —2010 Book News Inc., Portland, Oregon ""Without any hesitation, I recommend this book to any researcher involved in the analysis of conformation and stability of biotechnology products (not necessarily limited to biopharmaceuticals)."" —Igor A Kaltashov. Future Science" Lundblad (pathology, U. of North Carolina at Chapel Hill) provides coverage of the range of technology used for the conformational analysis of biopharmaceutical polymers, intending to provide sufficient information and extensive references to establish the basis for the selection of a specific experimental approach that would be most cost-effective in the study of biopolymer conformation. Technologies addressed include native electrophoresis, affinity chromatography, size-exclusion chromatography, analytical ultracentrifugation, differential scanning calorimetry, light scattering, luminescence, near-infrared spectroscopy, mid-infrared and Fourier transform infrared spectroscopy, Raman spectroscopy, UV-VIS spectroscopy, optical rotatory dispersion and circular dichroism, nuclear magnetic resonance, chemical probes, hydrogen exchange, chemical modification,. immunology, and limited proteolysis -2010 Book News Inc., Portland, Oregon Without any hesitation, I recommend this book to any researcher involved in the analysis of conformation and stability of biotechnology products (not necessarily limited to biopharmaceuticals). -Igor A Kaltashov. Future Science Author InformationAfter postdoctoral work at Rockefeller University, New York, Dr. Roger L. Lundblad joined the faculty of the University of North Carolina at Chapel Hill in 1968. He joined the Hyland division of Baxter Healthcare in 1990. Currently, he is an independent consultant and biotechnology writer based in Chapel Hill, North Carolina. He is an adjunct professor of pathology at the University of North Carolina at Chapel Hill and an editor in chief of the Internet Journal of Genomics and Proteomics. Tab Content 6Author Website:Countries AvailableAll regions |